INSP Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 4.18%, SMA50 -18.16%, SMA200 -32.86%). The stock’s 14-day RSI is 46.48 (neutral), while the ATR of 5.86 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -65.59% below its high and over 28.13% above its low. Average 10-day trading volume of 854.40 thousand shares is below the 3-month average of 1.10 million, indicating normal recent market interest.

Inspire Medical Systems, Inc. has 29.57 million shares outstanding. The public float is 26.74 million shares, elevated short interest at 11.40% of float. This equals 2.51 million shares. The short ratio is 4.3 days. Institutional investors hold 121.56% of the float. Insiders own 1.17%. NELSON MARILYN C holds 74.10 thousand shares, Herbert Timothy P. has 63.66 thousand shares and Buchholz Richard has 44.87 thousand shares. Over the past six months, insider transactions show net selling. They sold 3.45 thousand shares across 3 transactions.

Inspire Medical Systems, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $165.76. This means the shares are trading below this model’s fair value.

Inspire Medical Systems, Inc. (NYSE:INSP) closed at $41.75 USD, gaining $0.40 (0.97%) from the previous close of $41.35. The stock is currently mid-range between its 52-week high and low $38.91 and $147.03. With a market capitalization of about $1.20 billion, Inspire Medical Systems, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.73). Key stats such as the average daily volume over the past year has been around 1.11 million shares, in line with its 52-week average. Headquartered in Golden Valley, MN, Inspire Medical Systems, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Timothy Herbert, the company employs approximately 1,246 people and listed since May 03, 2018. Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S.

Wall Street analysts project EPS growth of 12.74% annually over the next five years. The latest quarter delivered EPS of $0.10. The next quarter is forecast at -$0.30. Next year's EPS is expected at $51.10. Analyst sentiment is neutral. Analyst rating data shows there are 22 Strong Buy ratings, 8 Buy ratings, 27 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $230.00 to $40.00. The high target offers 450.9% upside. The low target suggests -4.19% downside. The mean target is $113.32. This offers 171.43% upside. Inspire Medical Systems, Inc. earnings surprise history is a mixed track record. The quarter that ended May 04, 2026, missed forecasts by -136.32%. The prior quarter beat by 139.13%. Over the last six quarters, Apple has recorded several small beats. These include 55.41% in February 10, 2025.

Inspire Medical Systems, Inc. trades at a P/E ratio of 9.14, slightly below the S&P 500 average, with a price-to-sales ratio of 1.3 and a price-to-book ratio of 1.5 suggesting the stock is closer to book value. The P/FCF stands at 12.33, also above market averages.

Our AI price prediction model suggests that Inspire Medical Systems, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -2.13%, with price expected at $40.86 by July 06, 2026, within a range of $38.81 to $43.09 3-Month Outlook: Projected fall of -62.13%, reaching $15.81 by September 18, 2026, with a range of $11.75 to $19.12. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by June 22, 2027, within a range of $0.00 to $0.00.

Inspire Medical Systems, Inc. (NYSE:INSP) shares are flat 2.41% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Inspire Medical Systems, Inc. trading at a premium to the broader market with a P/E of 9.14. Analyst sentiment is cautious, with the majority of ratings in In-Line territory and a mean price target of $174.31, suggesting 317.51% upside. Our AI forecast model points to short-term weakness (-2.13% over two weeks), a medium-term fall (-62.13% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.